Search

everythinglearnresearchcommunity

for

Search:↓

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Mushroom beta-glucans from Ganoderma lucidum can reduce tumor size and metastasis in cancer.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

Deleting TNFα gene reduces skin cancer risk in certain mice.

The cat had liver cancer and a related hair loss condition, with a likely cause being bile duct cancer.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

A woman with lymphoma had a rare skin rash on her scalp and forehead, which was hard to diagnose but responded well to treatment.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

New compounds may help treat prostate cancer by reducing cell growth.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

A 69-year-old smoker was wrongly diagnosed with lung cancer but actually had a rare lymphatic system disorder.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

CEC levels may be a useful marker for predicting prostate cancer progression.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

A 90-year-old woman's hand lesion was a rare, aggressive skin cancer treated successfully with surgery.

Examining scalp tissue under a microscope helps diagnose and understand hair loss diseases.

Lipase H is important for hair follicle function and shaping hair fibers.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.